SAM L. BARKER

Insider Reports History

Location
Hopewell, NJ
Signature
/s/ Samuel L. Barker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SAM L. BARKER:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Director Common Stock 40,415 $133,976 $3.32 30 Jun 2023 Direct
LEXICON PHARMACEUTICALS, INC. Director Restricted Stock Units 89,312 $96,442 $2.62 03 Jun 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Common Stock 124,459 $63,474 $0.5100 13 May 2025 Direct
LEXICON PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 103,806 03 Jun 2025 Direct
Cyclacel Pharmaceuticals, Inc. Director Stock Option (right to buy) 42,438 30 Jun 2023 Direct

Insider Reports Filed by SAM L. BARKER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 03 Jun 2025 2 $0 4 Director 03 Jun 2025, 16:22
LXRX LEXICON PHARMACEUTICALS, INC. 13 May 2025 2 $0 4 Director 13 May 2025, 17:50
LXRX LEXICON PHARMACEUTICALS, INC. 13 May 2024 2 $0 4 Director 13 May 2024, 16:01
LXRX LEXICON PHARMACEUTICALS, INC. 28 Apr 2024 2 $0 4 Director 29 Apr 2024, 16:17
CYCC Cyclacel Pharmaceuticals, Inc. 30 Jun 2023 2 $0 4 Director 03 Jul 2023, 16:57
LXRX LEXICON PHARMACEUTICALS, INC. 21 May 2023 2 $0 4 Director 22 May 2023, 16:02
LXRX LEXICON PHARMACEUTICALS, INC. 28 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:22
CYCC Cyclacel Pharmaceuticals, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 16:10
LXRX LEXICON PHARMACEUTICALS, INC. 21 May 2022 2 $0 4 Director 23 May 2022, 16:13
LXRX LEXICON PHARMACEUTICALS, INC. 30 Apr 2022 2 $0 4 Director 02 May 2022, 16:12
CYCC Cyclacel Pharmaceuticals, Inc. 30 Nov 2021 1 -$42.86 4 Director 02 Dec 2021, 15:07
CYCC Cyclacel Pharmaceuticals, Inc. 24 Aug 2021 1 +$5,000 4 Director 25 Aug 2021, 16:16
CYCC Cyclacel Pharmaceuticals, Inc. 15 Jun 2021 2 $0 4 Director 17 Jun 2021, 16:08